病例报告:维拉帕米预防丛集性头痛发作前症状期。

IF 4 2区 医学 Q1 CLINICAL NEUROLOGY
Headache Pub Date : 2025-09-01 Epub Date: 2025-07-15 DOI:10.1111/head.15008
Yajin Wu, Mingjie Zhang, Zhao Dong, Shengyuan Yu
{"title":"病例报告:维拉帕米预防丛集性头痛发作前症状期。","authors":"Yajin Wu, Mingjie Zhang, Zhao Dong, Shengyuan Yu","doi":"10.1111/head.15008","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>As the first-line preventive treatment of cluster headache (CH), verapamil provides less relief in the initial stage of medication and takes 2-3 weeks to achieve optimal efficacy. Approximately one third of patients with CH have symptoms before the cluster period arrives, such as local pain, sensory abnormalities, and autonomic symptoms, which are called pre-episode symptoms (PES); however, no study has examined the role of prophylactic administration during this period.</p><p><strong>Case: </strong>Here, we report a patient with CH who was treated with verapamil at the beginning of the PES phase five times over 5 years to avoid the onset of CH. Unfortunately, CH recurred after the latest PES phase due to delayed treatment.</p><p><strong>Conclusion: </strong>Prophylactic treatment in the PES phase of CH might reduce the severity or prevent the onset of headache during the episode phase, suggesting the feasibility of initiating prophylactic treatment in the PES phase. A large clinical trial is necessary to verify this.</p>","PeriodicalId":12844,"journal":{"name":"Headache","volume":"65 8","pages":"1492-1494"},"PeriodicalIF":4.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Case report: Prophylactic administration of verapamil for cluster headache during the pre-episode symptoms phase.\",\"authors\":\"Yajin Wu, Mingjie Zhang, Zhao Dong, Shengyuan Yu\",\"doi\":\"10.1111/head.15008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>As the first-line preventive treatment of cluster headache (CH), verapamil provides less relief in the initial stage of medication and takes 2-3 weeks to achieve optimal efficacy. Approximately one third of patients with CH have symptoms before the cluster period arrives, such as local pain, sensory abnormalities, and autonomic symptoms, which are called pre-episode symptoms (PES); however, no study has examined the role of prophylactic administration during this period.</p><p><strong>Case: </strong>Here, we report a patient with CH who was treated with verapamil at the beginning of the PES phase five times over 5 years to avoid the onset of CH. Unfortunately, CH recurred after the latest PES phase due to delayed treatment.</p><p><strong>Conclusion: </strong>Prophylactic treatment in the PES phase of CH might reduce the severity or prevent the onset of headache during the episode phase, suggesting the feasibility of initiating prophylactic treatment in the PES phase. A large clinical trial is necessary to verify this.</p>\",\"PeriodicalId\":12844,\"journal\":{\"name\":\"Headache\",\"volume\":\"65 8\",\"pages\":\"1492-1494\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Headache\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/head.15008\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Headache","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/head.15008","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:维拉帕米作为集束性头痛(CH)的一线预防治疗药物,在用药初期缓解效果较差,需2-3周才能达到最佳疗效。大约三分之一的CH患者在聚集期到来之前就有症状,如局部疼痛、感觉异常和自主神经症状,这些被称为发作前症状(PES);然而,没有研究检查在这一时期预防管理的作用。病例:在这里,我们报告了一名CH患者,他在PES期开始时接受了维拉帕米治疗,在5年内进行了5次治疗,以避免CH的发生。不幸的是,由于延迟治疗,CH在最新PES期后复发。结论:癫痫发作期预防性治疗可减轻发作期头痛的严重程度或预防发作期头痛的发生,提示在癫痫发作期开始预防性治疗的可行性。有必要进行大规模的临床试验来证实这一点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Case report: Prophylactic administration of verapamil for cluster headache during the pre-episode symptoms phase.

Background: As the first-line preventive treatment of cluster headache (CH), verapamil provides less relief in the initial stage of medication and takes 2-3 weeks to achieve optimal efficacy. Approximately one third of patients with CH have symptoms before the cluster period arrives, such as local pain, sensory abnormalities, and autonomic symptoms, which are called pre-episode symptoms (PES); however, no study has examined the role of prophylactic administration during this period.

Case: Here, we report a patient with CH who was treated with verapamil at the beginning of the PES phase five times over 5 years to avoid the onset of CH. Unfortunately, CH recurred after the latest PES phase due to delayed treatment.

Conclusion: Prophylactic treatment in the PES phase of CH might reduce the severity or prevent the onset of headache during the episode phase, suggesting the feasibility of initiating prophylactic treatment in the PES phase. A large clinical trial is necessary to verify this.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Headache
Headache 医学-临床神经学
CiteScore
9.40
自引率
10.00%
发文量
172
审稿时长
3-8 weeks
期刊介绍: Headache publishes original articles on all aspects of head and face pain including communications on clinical and basic research, diagnosis and management, epidemiology, genetics, and pathophysiology of primary and secondary headaches, cranial neuralgias, and pains referred to the head and face. Monthly issues feature case reports, short communications, review articles, letters to the editor, and news items regarding AHS plus medicolegal and socioeconomic aspects of head pain. This is the official journal of the American Headache Society.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信